Jack Meehan

Analyst

Nephron

Equibles does not estimate personal net worth.

About Jack Meehan

Jack Meehan is recorded as Analyst at Nephron. Jack Meehan has spoken on 3 earnings calls across 3 companies, most recently for Bio-Rad Laboratories, Inc. on February 12, 2026. Those appearances were for Bio-Rad Laboratories, Inc. (BIO), QuidelOrtho Corp (QDEL) and Bruker Corp (BRKR). The companies whose calls Jack Meehan spoke on are classified in the Healthcare sector.

Jack Meehan on recent calls

“And then maybe the last one for – I was trying to do like a bridge from 2025 to 2026 on top margin. So, you ended here at 12.1%. You have the in-process R&D should go away.”

Analyst — Nephron, Bio-Rad Laboratories, Inc. Q4 FY2025 Earnings Call · February 12, 2026

“I wanted to talk a little bit more about the supply chain and what you're seeing here. Obviously, the third quarter came in better than expected, but it sounds like you're still expressing a little caution about the fourth quarter.”

Analyst — Nephron, Bruker Corp Q3 FY2022 Earnings Call · November 3, 2022